DisCoVeRy Trial Results Mean More Bad News for Remdesivir—No Clinical Benefit

INSERM, a successor to the French National Institute of Health, recently had results from the Phase 3 DisCoVeRy clinical trial published in The Lancet, Infectious … Continue reading DisCoVeRy Trial Results Mean More Bad News for Remdesivir—No Clinical Benefit